Mecasermin (Astellas/OrphanPacific)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMecasermin (Astellas/OrphanPacific)
Drug Alias NameMecasermina (Astellas/OrphanPacific)美卡舍明（Astellas/OrphanPacific）Mecaserminum (Astellas/OrphanPacific)Somatomedin-1 (Astellas/OrphanPacific)Somazon
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsGrowth hormone deficiencyDiabetes Mellitus, LipoatrophicMyocardial Infarction +[7] 
Global Approved IndicationsGrowth hormone deficiencyDiabetes Mellitus, LipoatrophicDwarfism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1994/10/05
Country/TerritoryUnited StatesNetherlandsIreland +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical CenterUniversity College CorkNational Institute Of Neurological Disorders And Stroke
Active IndicationsGrowth hormone deficiencyDiabetes Mellitus, LipoatrophicDwarfism
Inactive IndicationsMyocardial InfarctionHeart FailureMultiple Sclerosis +[4] 

Other Information

ATC CodeH01AC03
Related LinksWikipediaDrugBankKEGG